Cargando…
Subset Analysis for Screening Drug–Drug Interaction Signal Using Pharmacovigilance Database
Many patients require multi-drug combinations, and adverse event profiles reflect not only the effects of individual drugs but also drug–drug interactions. Although there are several algorithms for detecting drug–drug interaction signals, a simple analysis model is required for early detection of ad...
Autores principales: | Noguchi, Yoshihiro, Tachi, Tomoya, Teramachi, Hitomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466158/ https://www.ncbi.nlm.nih.gov/pubmed/32806518 http://dx.doi.org/10.3390/pharmaceutics12080762 |
Ejemplares similares
-
Angioedema Caused by Drugs That Prevent the Degradation of Vasoactive Peptides: A Pharmacovigilance Database Study
por: Noguchi, Yoshihiro, et al.
Publicado: (2021) -
Review of Statistical Methodologies for Detecting Drug–Drug Interactions Using Spontaneous Reporting Systems
por: Noguchi, Yoshihiro, et al.
Publicado: (2019) -
Improved Detection Criteria for Detecting Drug-Drug Interaction Signals Using the Proportional Reporting Ratio
por: Noguchi, Yoshihiro, et al.
Publicado: (2020) -
Differences in detected safety signals between benzodiazepines and non-benzodiazepine hypnotics: pharmacovigilance study using a spontaneous reporting system
por: Toyoshima, Manabu, et al.
Publicado: (2021) -
Verification of the “Upward Variation in the Reporting Odds Ratio Scores” to Detect the Signals of Drug–Drug Interactions
por: Noguchi, Yoshihiro, et al.
Publicado: (2021)